使用降糖药物管理 2 型糖尿病患者。

ISRN endocrinology Pub Date : 2012-01-01 Epub Date: 2012-04-04 DOI:10.5402/2012/601380

G P Carnevale Schianca, D Sola, L Rossi, G P Fra, E Bartoli

{"title":"使用降糖药物管理 2 型糖尿病患者。","authors":"G P Carnevale Schianca, D Sola, L Rossi, G P Fra, E Bartoli","doi":"10.5402/2012/601380","DOIUrl":null,"url":null,"abstract":"Aims and Scope. Aims of the paper are to suggest the best treatment to improve the glycemic control in patients with Type 2 diabetes using hypoglycemic agents, in particularly, we think that every patient is different from another one in terms of BMI, family history, duration of the disease and so on. We propose for every clinical aspect the best hypoglycemic agents to use, considering the scientific evidence and physiopathology.","PeriodicalId":89576,"journal":{"name":"ISRN endocrinology","volume":"2012 ","pages":"601380"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335186/pdf/","citationCount":"0","resultStr":"{\"title\":\"The management of type 2 diabetic patients with hypoglycemic agents.\",\"authors\":\"G P Carnevale Schianca, D Sola, L Rossi, G P Fra, E Bartoli\",\"doi\":\"10.5402/2012/601380\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aims and Scope. Aims of the paper are to suggest the best treatment to improve the glycemic control in patients with Type 2 diabetes using hypoglycemic agents, in particularly, we think that every patient is different from another one in terms of BMI, family history, duration of the disease and so on. We propose for every clinical aspect the best hypoglycemic agents to use, considering the scientific evidence and physiopathology.\",\"PeriodicalId\":89576,\"journal\":{\"name\":\"ISRN endocrinology\",\"volume\":\"2012 \",\"pages\":\"601380\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335186/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ISRN endocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5402/2012/601380\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2012/4/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ISRN endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5402/2012/601380","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2012/4/4 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

目的和范围。本文的目的是提出使用降糖药物改善 2 型糖尿病患者血糖控制的最佳治疗方法，特别是，我们认为每个患者在体重指数、家族史、病程等方面都不尽相同。考虑到科学证据和生理病理学，我们针对每个临床方面提出了最佳降糖药物的使用建议。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The management of type 2 diabetic patients with hypoglycemic agents.

Aims and Scope. Aims of the paper are to suggest the best treatment to improve the glycemic control in patients with Type 2 diabetes using hypoglycemic agents, in particularly, we think that every patient is different from another one in terms of BMI, family history, duration of the disease and so on. We propose for every clinical aspect the best hypoglycemic agents to use, considering the scientific evidence and physiopathology.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

ISRN endocrinology

自引率

0.00%

发文量